Drugmaker Endo Says Bankruptcy Likely Imminent -- WSJ

Dow Jones
2022/08/09

By Alexander Gladstone

 

Endo International PLC, the pharmaceutical manufacturer facing thousands of lawsuits alleging it fueled the opioid addiction crisis, said Tuesday that it is likely to file for bankruptcy imminently.

The company said that it is in negotiations with a group of senior lenders that it expects will result in an agreement for a chapter 11 filing. Endo also said that it is in discussions with opioid litigants as well as other creditors but didn't say that it has reached a proposed deal with them.

The Wall Street Journal reported last month that Endo was moving toward filing for bankruptcy without an agreement in place with the various states, municipalities, and private plaintiffs suing the company for its role in producing and distributing opioids. Endo has denied liability in connection with the opioid crisis.

Write to Alexander Gladstone at alexander.gladstone@wsj.com

 

$(END)$ Dow Jones Newswires

August 09, 2022 09:32 ET (13:32 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10